Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Polycystic Ovary Syndrome

3,4-methylenedioxyamphetamine has been researched along with Polycystic Ovary Syndrome in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Polycystic Ovary Syndrome: A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.

Research Excerpts

ExcerptRelevanceReference
"An autocrine role of NGF in breast cancer and epithelial ovarian cancer (EOC) is evident now."1.35Neurotrophin in obstetrics and gynaecology. ( Bose, CK, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bose, CK1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Polycystic Ovary Syndrome

ArticleYear
Neurotrophin in obstetrics and gynaecology.
    Journal of stem cells, 2009, Volume: 4, Issue:4

    Topics: Animals; Breast Neoplasms; Embryo Implantation; Endometriosis; Female; Fetal Growth Retardation; Gyn

2009